Hong Kong Pharma Digital Technology Holdings Revenue 1970-1969 | HKPD
Hong Kong Pharma Digital Technology Holdings revenue from 1970 to 1969. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Hong Kong Pharma Digital Technology Holdings Annual Revenue (Millions of US $) |
|---|
| Hong Kong Pharma Digital Technology Holdings Quarterly Revenue (Millions of US $) |
|---|
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oaktree Acquisition III Life Sciences (OACC) | United States | $0.224B | 0.00 |
| PicoCELA (PCLA) | Japan | $0.173B | 0.00 |
| Aduro Clean Technologies (ADUR) | Canada | $0.156B | 0.00 |
| Range Capital Acquisition (RANG) | United States | $0.140B | 0.00 |
| Tavia Acquisition (TAVI) | $0.139B | 0.00 | |
| CO2 Energy Transition (NOEM) | $0.095B | 0.00 | |
| Leishen Energy Holding (LSE) | China | $0.089B | 0.00 |
| YHN Acquisition I (YHNA) | $0.081B | 0.00 | |
| Youxin Technology (YAAS) | $0.065B | 0.00 | |
| YSX Tech (YSXT) | China | $0.062B | 0.00 |
| New Century Logistics (BVI) (NCEW) | Hong Kong, SAR China | $0.026B | 0.00 |
| Sky Quarry (SKYQ) | $0.016B | 0.00 | |
| Flowco Holdings (FLOC) | $0.000B | 0.00 |